News - Page 31 of 80 - Yokohama City University

2022-10-12

Comparison of the blood pressure management between sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

The cardiovascular and renal protective effects of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide 1 receptor agonists (GLP-1Ras) are enhanced by low/controlled blood pressure (BP).

2022-09-26

Immune Checkpoint Inhibitors do not Increase Short-term Risk of Hypertension in Cancer Patients: A Systematic Literature Review and Meta-analysis

Background: Immune checkpoint inhibitors (ICIs) are becoming widely used for novel cancer treatments. Immune-related adverse events, including cardiac toxicity, are frequently observed following immune checkpoint inhibitor (ICI) use. However, little is known regarding the association between ICIs initiation and hypertension in cancer patients.

2022-09-13

Improved immune response to the third COVID-19 mRNA vaccine dose in hemodialysis patients

Introduction A third dose of SARS-CoV-2 mRNA vaccine has been administered in several countries.1,2 Patients with end-stage kidney disease have a weak immune response to 2-sessional doses of the mRNA vaccine.3, 4, 5, 6, 7 Because patients undergoing hemodialysis (HD) are at a high risk for COVID-19 severity and death, they have been prioritized in vaccination programs worldwide.8,9

2022-09-08

Association between fruit/vegetable intake and mortality risk: results of the Japan Public Health Center-based Prospective Study (JPHC Study)

Key points in the announcement ・In a Japanese cohort, the association between fruit and vegetable intake and the risk of all-cause and specific-cause mortality was evaluated.